Abstract:It is necessary to apply a precise standard to predict the oncological outcomes among heterogeneous subgroups of N1 disease ranging from level 10 to 14. Although International Association for the Study of Lung Cancer (IASLC) proposed a new N descriptor in the 8th edition of the TNM Classification, lack of dissection on level 13 and level 14 may affect the efficacy of new classification. In this study, we tested a hypothesized classification strategy based on systematic dissection of N1 node from level 10 to level 14. From March 2007 to December 2014, 156 consecutive patients of non-small cell lung cancer, treating with lobectomy and systematic mediastinal lymphadenectomy, were investigated. Nodes from level 10 to 12 were dissected during operation. Intrapulmonary lymph nodes (level 13-14) were retrieved after surgery. The data were prospectively collected and retrospectively analyzed. All cases were divided into two categories according to the 8th edition of the TNM Classification: pN1a was defined as N1 at a single station, while pN1b was defined as N1 at multiple stations. Then, in our proposed classification, N1a (modified) was defined as single level of N1 station involved (not including single level 10 or 11 spread) or level 13 and/or 14 involved, while N1b (modified) was defined as single level 10 or 11 spread or multiple levels of N1 node involvement (not including level 13 and 14 spread). The association between the N1 subgroup status and survival was explored separately using 8th IASLC classification and hypothesized classification. In the whole cohort, a mean ± SD of 13.1±7.1 N2 nodes and 12.0+5.2 N1 nodes per case were collected. There were 4.7±3.1 nodes from level 13 and 14. The difference in 5-year overall survival between pN1a and pN1b was not significant (73.9% versus 65.7%, p=0.371). However, the difference in 5-year overall survival between N1a (modified) and N1b (modified) was significant (79.1% versus 60.2%, p=0.018). Multivariate analysis showed the revised N1 classification was an independent prognostic factor for NSCLC (versus N1a, the hazard ratio [HR] of N1b for OS was 2.120, 95% confidence interval [CI]: 1.083-4.151, p=0.028). However, the 8th edition IASLC N1 descriptors was not an independent prognostic factor (versus pN1a, HR of pN1b was 1.419, 95% CI: 0.710-2.837, p=0.322). The hypothesized N1 classification in present study was shown to be a better descriptor to express the outcome than 8th edition of the TNM Classification of IASLC. More data are needed to validate this proposal.

OA 16.08 A Modified Pathological N1 Classification Strategy Based on Systematic Dissection of N1 Nodes from Level 10 to 14 for Non-Small Cell Lung Cancer

[A modified pathological N1 classification strategy based on the systematic dissection of N1 nodes for non-small cell lung cancer].

Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer

The Lymph node ratio optimizes staging in patients with small intestinal neuroendocrine tumors.

Recommended changes for the 8th edition of the TNM classification for lung cancer-the findings of a single-institution evaluation

Analysis of the Relationship Between the Anatomical Location of Intrapulmonary Metastatic Lymph Nodes and Relapse Risk and Survival in Patients with N1 Non-Small Cell Lung Cancer

Prognostic significance of the N1 classification pattern: a meta-analysis of different subclassification methods

Risk Analyses of N2 Lymph-Node Metastases in Patients with T1 Non-Small Cell Lung Cancer: a Multi-Center Real-World Observational Study in China

p53 mutations in the non‐neoplastic mucosa of the human stomach showing intestinal metaplasia

Prognostic analysis of node status of 1 851 non-small cell lung cancer patients on the basis of the eighth TNM staging system: A cohort study

Role of Pathologic Single-N and Multiple-N Descriptors in Resected Non-Small Cell Lung Cancer

A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients

ASO Visual Abstract: A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgical Resected Non-Small Cell Lung Cancer Patients

Prognostic Impact of Lymphadenectomy on Outcomes of Sublobar Resection for Stage IA Non–small Cell Lung Cancer ≤2 Cm

Preoperative Lymph Node Assessment in Surgically Resected Pathologic T1 Lung Cancer Patients: Real World Clinical Practice in China.

OA07.02 Omitting Intrapulmonary Lymph Node Retrieval May Affect the Oncological Outcome of Pn0 Lung Cancer Patients: A Propensity Score Match Analysis

Validation of the stage groupings in the 8th edition of the TNM classification for lung cancer.

A Modified Subclassification to Evaluate the Survival of Patients with N3 Gastric Cancer: an International Database Study

Validation Study for the N Descriptor of the Newly Proposed Ninth Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer

The prognostic significance of lymph nodes in patients with pT1c33N0M0 non-small cell lung cancer: a retrospective study

Clinical Analysis of Sixty-Four Patients with T1an2m0 Stage Non-Small Cell Lung Cancer Who Had Undergone Resection